InsidersTradesSigma
Track the 마크로젠 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 마크로젠 has recorded 127 insider filings. Market capitalisation: €123.2bn. The latest transaction was reported on 25 June 2026 (Other). Among the most active insiders: 김창훈. The full history is free.
127
Insider Decl.
n/a
Thresholds
n/a
21 ops.
Buy Volume
n/a
11 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,979 of 29,057 companies
34.0
score / 100
Value35
Quality33
FCF yld-10.0%
Earn yld1.5%
EV/EBITDA12.0x
ROE·
Gross mgn36%
Net mgn1.0%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 June 2026
Declarations127 total
25 of 127 declarations
Acerca de 마크로젠
Macrogen es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en servicios genómicos y biotecnológicos.